256 related articles for article (PubMed ID: 31324163)
21. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.
Ho DM; Hsu CY; Wong TT; Chiang H
J Neurooncol; 2001 Aug; 54(1):77-85. PubMed ID: 11763426
[TBL] [Abstract][Full Text] [Related]
22. Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index.
Asai A; Hoshino T; Edwards MS; Davis RL
Childs Nerv Syst; 1992 Aug; 8(5):273-8. PubMed ID: 1394266
[TBL] [Abstract][Full Text] [Related]
23. The clinical and prognostic relevance of grading in intracranial ependymomas.
Ernestus RI; Schröder R; Stützer H; Klug N
Br J Neurosurg; 1997 Oct; 11(5):421-8. PubMed ID: 9474274
[TBL] [Abstract][Full Text] [Related]
24. Epithelial differentiation and proliferative potential in spinal ependymomas.
Takeuchi H; Kubota T; Sato K; Llena JF; Hirano A
J Neurooncol; 2002 May; 58(1):13-9. PubMed ID: 12160136
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
[TBL] [Abstract][Full Text] [Related]
26. Histologic prognostic factors in ependymoma.
Schiffer D; Chiò A; Giordana MT; Migheli A; Palma L; Pollo B; Soffietti R; Tribolo A
Childs Nerv Syst; 1991 Aug; 7(4):177-82. PubMed ID: 1933913
[TBL] [Abstract][Full Text] [Related]
27. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.
Tarapore PE; Modera P; Naujokas A; Oh MC; Amin B; Tihan T; Parsa AT; Ames CP; Chou D; Mummaneni PV; Weinstein PR
Neurosurgery; 2013 Aug; 73(2):247-55; discussion 255. PubMed ID: 23670032
[TBL] [Abstract][Full Text] [Related]
28. Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma.
Wolfsberger S; Fischer I; Höftberger R; Birner P; Slavc I; Dieckmann K; Czech T; Budka H; Hainfellner J
Am J Surg Pathol; 2004 Jul; 28(7):914-20. PubMed ID: 15223962
[TBL] [Abstract][Full Text] [Related]
29. A case of cervicomedullary junction tanycytic ependymoma associated with marked cyst formation.
Ito T; Ozaki Y; Nakagawara J; Nakamura H; Tanaka S; Nagashima K
Brain Tumor Pathol; 2005; 22(1):29-33. PubMed ID: 18095101
[TBL] [Abstract][Full Text] [Related]
30. Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival.
Wostrack M; Ringel F; Eicker SO; Jägersberg M; Schaller K; Kerschbaumer J; Thomé C; Shiban E; Stoffel M; Friedrich B; Kehl V; Vajkoczy P; Meyer B; Onken J
J Neurosurg Spine; 2018 Jun; 28(6):654-662. PubMed ID: 29521579
[TBL] [Abstract][Full Text] [Related]
31. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
Lin Y; Jea A; Melkonian SC; Lam S
J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
[TBL] [Abstract][Full Text] [Related]
32. Clear cells are associated with proliferative activity in ependymoma: a quantitative study.
Ishizawa K; Komori T; Aihara Y; Maruyama T; Okada Y; Ikuta S; Muragaki Y; Hirose T; Homma T; Sasaki A
Clin Neuropathol; 2012; 31(3):146-51. PubMed ID: 22551919
[TBL] [Abstract][Full Text] [Related]
33. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic use of D2-40 and annexin-1 in ependymal tumors].
Wang YF; Piao YS; Lu DH; Chen L; Wang W; Yang H; Wei LF
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):595-8. PubMed ID: 22177242
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
Korshunov A; Golanov A; Timirgaz V
J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
[TBL] [Abstract][Full Text] [Related]
36. Intracranial ependymoma.
Maksoud YA; Hahn YS; Engelhard HH
Neurosurg Focus; 2002 Sep; 13(3):e4. PubMed ID: 15844876
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of chromosome 1q gain in intracranial ependymomas.
Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
[TBL] [Abstract][Full Text] [Related]
38. Spinal ependymomas. Part 1: Intramedullary ependymomas.
Klekamp J
Neurosurg Focus; 2015 Aug; 39(2):E6. PubMed ID: 26235023
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of localization and grading in intracranial ependymomas of childhood.
Ernestus RI; Schröder R; Stützer H; Klug N
Childs Nerv Syst; 1996 Sep; 12(9):522-6. PubMed ID: 8906366
[TBL] [Abstract][Full Text] [Related]
40. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]